Article Details
Retrieved on: 2025-06-21 06:54:46
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Schonfeld Strategic Advisors LLC owned approximately 3.97% of Galmed Pharmaceuticals at the end of the most recent reporting period. Institutional ...
Article found on: www.defenseworld.net
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here